BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2452 related articles for article (PubMed ID: 8600684)

  • 21. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.
    Penna A; Missale G; Lamonaca V; Pilli M; Mori C; Zanelli P; Cavalli A; Elia G; Ferrari C
    Hepatology; 2002 May; 35(5):1225-36. PubMed ID: 11981773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
    Rosen HR; Miner C; Sasaki AW; Lewinsohn DM; Conrad AJ; Bakke A; Bouwer HG; Hinrichs DJ
    Hepatology; 2002 Jan; 35(1):190-8. PubMed ID: 11786976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.
    Nelson DR; Marousis CG; Davis GL; Rice CM; Wong J; Houghton M; Lau JY
    J Immunol; 1997 Feb; 158(3):1473-81. PubMed ID: 9013994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
    Murakami Y; Minami M; Daimon Y; Okanoue T
    J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus immunopathogenesis.
    Chisari FV; Ferrari C
    Annu Rev Immunol; 1995; 13():29-60. PubMed ID: 7612225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury.
    Rosen HR
    Liver Transpl; 2003 Nov; 9(11):S35-43. PubMed ID: 14586893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunopathology of hepatitis B antigen positive and negative active chronic hepatitis.
    Williams R
    Dev Biol Stand; 1975; 30():341-9. PubMed ID: 1081961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.
    Ballardini G; Groff P; Pontisso P; Giostra F; Francesconi R; Lenzi M; Zauli D; Alberti A; Bianchi FB
    J Clin Invest; 1995 May; 95(5):2067-75. PubMed ID: 7738174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of chronic hepatitis C virus infection.
    Nelson DR; Lau JY
    Antivir Ther; 1998; 3(Suppl 3):25-35. PubMed ID: 10726053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Action mechanism in immunopathogenesis and clearance of HBV].
    Im SJ; Sung YC
    Korean J Hepatol; 2006 Jun; 12(2):154-62. PubMed ID: 16804340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune mechanisms in chronic hepatitis B and delta virus infections.
    McFarlane BM; Bridger CB; Smith HM; Antonov KA; Naoumov N; Williams R; McFarlane IG
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):615-21. PubMed ID: 8590155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive liver injury in chronic hepatitis C infection is related to altered cellular immune response and to different citokine profile.
    Cecere A; Marotta F; Vangieri B; Tancredi L; Gattoni A
    Panminerva Med; 2004 Sep; 46(3):171-87. PubMed ID: 15510086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
    Wirth S; Guidotti LG; Ando K; Schlicht HJ; Chisari FV
    J Immunol; 1995 Mar; 154(5):2504-15. PubMed ID: 7868916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.
    Cabrera R; Tu Z; Xu Y; Firpi RJ; Rosen HR; Liu C; Nelson DR
    Hepatology; 2004 Nov; 40(5):1062-71. PubMed ID: 15486925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immune response induced by hepatitis B virus principal antigens.
    Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
    Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury.
    Tiegs G
    Z Gastroenterol; 2007 Jan; 45(1):63-70. PubMed ID: 17236122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunopathology of chronic viral hepatitis.
    Desmet VJ
    Hepatogastroenterology; 1991 Feb; 38(1):14-21. PubMed ID: 1902815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Infiltrating T-cells in primary biliary cirrhosis recognize mitochondrial epitopes].
    Löhr H; Fleischer B; Gerken G; Meyer zum Büschenfelde KH; Manns M
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():99-103. PubMed ID: 7483731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?
    Missale G; Cariani E; Ferrari C
    Dig Liver Dis; 2004 Nov; 36(11):703-11. PubMed ID: 15570998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 123.